Can Dogs Get Herpes? Understanding Canine Herpesvirus (CHV-1) in 2026

What Is Canine Herpesvirus (CHV-1) in Dogs?

Yes, dogs can get herpes — but it's nothing like the human version. Canine herpesvirus type 1 (CHV-1) is a species-specific alphaherpesvirus that infects only canids (dogs, wolves, coyotes). You cannot catch it from your dog, and your dog cannot catch human herpes from you.

CHV-1 is widespread in the global dog population. Seroprevalence studies — which test for antibodies indicating past exposure — suggest that 40% to 90% of adult dogs have been exposed to the virus at some point, depending on the region and population sampled. Most adult dogs experience mild or entirely asymptomatic infections. The virus then establishes lifelong latency in nerve ganglia and lymphoid tissue, meaning it remains dormant but can reactivate during periods of stress or immunosuppression.

The real danger lies with neonatal puppies under 3 weeks of age. In these puppies, CHV-1 causes a rapidly progressive, often fatal systemic disease known as fading puppy syndrome. Mortality rates in infected neonates can exceed 80–100% in untreated litters, making CHV-1 one of the most significant infectious threats in breeding kennels.

What Are the Symptoms of Canine Herpesvirus?

CHV-1 symptoms vary dramatically depending on the dog's age and immune status. The virus targets endothelial cells (blood vessel linings), causing vasculitis, hemorrhage, and organ necrosis in susceptible puppies. In adults, it primarily affects mucosal surfaces of the respiratory and reproductive tracts.

Severity Level	Puppies (0–3 Weeks)	Adult Dogs
Early Warning Signs	Excessive crying/restlessness, failure to nurse, weakness, chilling (subnormal body temperature below 94°F / 34.4°C)	Mild nasal discharge, occasional sneezing, transient cough, mild conjunctivitis
Progressing Symptoms	Yellow-green nasal discharge, abdominal bloating/pain, pale or bluish mucous membranes, soft yellowish feces, hemorrhages on gums or belly skin	Persistent cough, vaginal discharge (in intact females), reduced appetite, mild lethargy
Advanced / Severe	Seizures, blindness, difficulty breathing, refusal to suckle entirely, coma, death within 24–48 hours of symptom onset	Pregnancy loss (resorption or abortion), stillborn puppies, kennel cough complex contribution, rare encephalitis

In puppies, the disease progression is alarmingly fast. A puppy that appears mildly lethargic in the morning can be moribund by evening. This is why breeders and owners of neonatal litters must maintain a high index of suspicion.

Risk Factors: Which Dogs Are Most Vulnerable?

While CHV-1 exposure is common across all breeds, the consequences of infection depend heavily on specific risk factors:

Breed predisposition: No specific breed is genetically more susceptible to CHV-1 infection. However, any breed kept in breeding kennel environments with high population density faces elevated exposure risk. Brachycephalic breeds (English Bulldogs, French Bulldogs, Pugs) may experience more severe respiratory complications due to their already compromised airway anatomy.

How Is Canine Herpesvirus Diagnosed?

Diagnosing CHV-1 requires veterinary laboratory testing. Clinical signs alone — especially in fading puppies — overlap with many other neonatal conditions including bacterial sepsis, canine parvovirus, and congenital defects. Your veterinarian will typically pursue a combination of the following:

Diagnostic Test	Estimated Cost (2026)	Turnaround Time	Best Use Case
PCR (swab or blood)	$80–$180	2–5 days	Confirming active infection in live puppies or adults
Necropsy with histopathology	$200–$500	7–14 days	Determining cause of death in deceased puppies
Serology (paired titers)	$60–$120 per sample	5–10 days	Screening breeding dogs; confirming recent exposure
CBC + biochemistry panel	$120–$250	Same day – 24 hours	Assessing overall health status and organ function
Virus isolation (culture)	$150–$300	5–10 days	Research or reference lab confirmation

Initial diagnostic workup — including exam, PCR, and bloodwork — typically costs $300–$600. If necropsy is needed for a deceased puppy, add $200–$500.

Can Canine Herpesvirus Be Treated or Cured?

There is no cure for CHV-1. Like all herpesviruses, it establishes lifelong latency after initial infection. Treatment focuses on supportive care for affected puppies and managing clinical signs in adults.

According to the Merck Veterinary Manual, treatment in neonatal puppies is largely supportive, and outcomes depend heavily on how quickly intervention begins.

Treatment Approach	Details	Target Population	Expected Outcome
Hyperimmune serum	Injection of serum from dogs with high CHV-1 antibody titers. Administered intraperitoneally. May be sourced from breeding kennel's own vaccinated dogs or commercial preparations where available.	Newborn puppies in affected litters (prophylactic or early treatment)	Moderate improvement in survival when given within first 48 hours of life. Not universally available.
Antiviral therapy (acyclovir/valacyclovir)	Oral or IV antiviral drugs that inhibit herpesvirus DNA replication. Dosing is determined by your veterinarian based on weight. Acyclovir has limited bioavailability in dogs; valacyclovir is better absorbed but more expensive.	Affected puppies (early stage) or adults with severe clinical signs	Variable. May reduce viral shedding and severity. Evidence is limited; use is off-label. Your vet will determine appropriate dosing.
Thermal support (incubator/warming)	Maintaining ambient temperature at 85–90°F (29.4–32.2°C) for neonates. CHV-1 replicates poorly at higher temperatures, so warming may directly inhibit viral replication while supporting immune function.	All affected puppies under 3 weeks	Critical supportive measure. Improves overall survival odds when combined with other treatments.
Fluid therapy & nutritional support	Subcutaneous or intravenous fluids to combat dehydration. Tube feeding or bottle supplementation with canine milk replacer (e.g., Esbilac or Royal Canin Babydog Milk) if puppy cannot nurse.	Puppies failing to nurse; dehydrated adults	Essential for survival. Prevents hypoglycemia and dehydration, which are common secondary killers.
Antibiotic therapy (secondary infection prevention)	Broad-spectrum antibiotics (e.g., amoxicillin-clavulanate) to prevent or treat secondary bacterial infections that exploit the weakened immune state. Your vet will select appropriate antibiotics.	All clinically affected dogs	Prevents opportunistic bacterial sepsis, a common co-mortality factor.

Important: Never administer human antiviral medications to your dog without explicit veterinary guidance. Dosages for dogs differ significantly from human dosing, and some formulations contain excipients that are toxic to canines. Always consult your veterinarian before starting any medication.

Prognosis and Life Expectancy

Prognosis depends almost entirely on the age of the dog at the time of infection:

Age at Infection	Prognosis	Mortality Rate	Long-Term Outlook
0–7 days old	Grave	80–100%	Most puppies die within 24–48 hours of symptom onset. Rare survivors may have permanent neurological deficits.
7–21 days old	Guarded to fair	20–50% with treatment	Puppies that survive past day 21 generally develop normal immune function and live normal lifespans, though they carry latent virus.
3+ weeks old	Good	Very low (<5%)	Mild or subclinical infection. Dog develops immunity and lives a normal lifespan with latent (dormant) virus.
Adult dogs	Excellent	Rarely fatal	Normal life expectancy. Primary concern is reproductive impact (infertility, pregnancy loss) and viral shedding to susceptible puppies.

Life expectancy for a dog that survives neonatal CHV-1 infection: Once a puppy passes the 3-week mark and recovers, life expectancy is generally normal for their breed. The latent virus does not typically cause progressive disease in immunocompetent adult dogs. However, the dog will intermittently shed virus during stress periods, which is a consideration if they later enter a breeding program.

Prevention Strategies

Prevention is far more effective than treatment for CHV-1, particularly in breeding operations:

Vaccination

A modified-live intranasal vaccine (EURICAN® CHV, manufactured by Boehringer Ingelheim) is available in many European countries and some other markets. In the United States, vaccine availability has historically been limited. Check with your veterinarian about current availability in your region, as product registrations change. Where available, the protocol typically involves:

• Initial dose at the time of mating or during early pregnancy (estrus)
• Booster dose 1–2 weeks before expected whelping date
• This ensures maximum colostral antibody transfer to puppies

Biosecurity Measures

• Isolate pregnant dams from other dogs during the last 3 weeks of pregnancy and the first 3 weeks after whelping. This is the single most effective management strategy.
• Quarantine new dogs entering a breeding kennel for a minimum of 14 days with serological testing before introduction.
• Limit visitor access to whelping areas. CHV-1 can be carried on hands and clothing, though it is a fragile virus that does not survive long in the environment (typically less than 24 hours on surfaces at room temperature).
• Disinfection: CHV-1 is an enveloped virus, making it susceptible to common disinfectants. A 1:32 dilution of household bleach (sodium hypochlorite), accelerated hydrogen peroxide products (e.g., Rescue™), or quaternary ammonium compounds are effective. Contact time of 10 minutes is recommended.
• Cesarean section and foster nursing: In high-risk situations, delivering puppies via C-section and placing them with a CHV-1-negative, vaccinated foster dam can prevent exposure during the critical neonatal window.

Pre-Breeding Screening

Serological screening of both the dam and sire before breeding can identify seronegative dogs (those never exposed) and seropositive dogs (potential latent carriers). Pairing decisions should consider minimizing risk — a seronegative dam bred to a seropositive sire faces risk of primary infection during pregnancy, which is the most dangerous scenario for the litter.

How Much Does CHV-1 Treatment Cost?

Treatment costs vary based on the number of affected puppies, severity, and how aggressively you and your veterinarian pursue intervention:

Scenario	Estimated Cost Range	What's Included
Single puppy — basic supportive care	$400–$1,200	Exam, PCR test, fluids, warming support, antibiotics, 1–2 follow-up visits
Single puppy — intensive care/hospitalization	$1,500–$4,000+	ICU incubator, IV fluids, antiviral therapy, round-the-clock monitoring, tube feeding, 3–7 day hospitalization
Entire litter affected (4–8 puppies)	$3,000–$12,000+	Multiple puppy treatments, necropsies for deceased puppies, dam evaluation, hyperimmune serum if available
Adult dog — mild respiratory infection	$200–$500	Exam, diagnostic testing, antibiotics, follow-up
Prevention (pre-breeding screening + vaccination)	$150–$400 per breeding cycle	Serology for dam and sire, vaccination doses (where available), isolation management costs

For breeders, the financial impact of a CHV-1 outbreak extends beyond veterinary bills. Loss of an entire litter represents the loss of puppy sales revenue ($1,500–$5,000+ per puppy depending on breed), plus the emotional toll on the breeding family.

Home Care and Daily Management

If your veterinarian has diagnosed CHV-1 and sent you home with a treatment plan, daily management is intensive but critical:

For Affected Puppies

• Maintain ambient temperature at 85–90°F (29.4–32.2°C) using a whelping box with a heat lamp, heating pad set on low (with escape area so puppy can move away from heat), or a commercial veterinary incubator like the Lyons Technologies Incubator. Monitor with a digital thermometer placed at puppy level — not above.
• Supplemental feeding every 2–3 hours using canine milk replacer. Use a pet nursing bottle or orogastric feeding tube (have your vet demonstrate proper tube feeding technique to avoid aspiration pneumonia). Target 1 mL of formula per ounce of body weight per feeding for the first week.
• Monitor weight daily using a gram scale. Puppies should gain 5–10% of their body weight per day. Weight loss or stagnation is a red flag requiring immediate vet contact.
• Hygiene: Wash hands thoroughly before and after handling affected puppies. Change clothing between handling affected and unaffected litters. Dispose of soiled bedding in sealed bags.
• Separate affected puppies from unaffected littermates if possible, though in practice the entire litter has usually been exposed by the time symptoms appear.

For Adult Dogs with Mild Infection

• Rest and reduced activity for 7–14 days
• Ensure adequate hydration — offer low-sodium chicken broth if water intake is reduced
• Complete any prescribed antibiotic course even if symptoms resolve
• Avoid contact with pregnant dogs, neonatal puppies, and immunocompromised dogs for at least 3 weeks

Frequently Asked Questions

This article is for informational purposes only and does not replace professional veterinary care. If you suspect your dog or puppies have canine herpesvirus, consult your veterinarian promptly for diagnosis and treatment. Sources referenced include the Merck Veterinary Manual, the American Veterinary Medical Association (AVMA), and peer-reviewed research published in veterinary infectious disease literature.